For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Global Presence

Cadila Pharmaceuticals has a multicultural, multilingual and multinational workforce of more than seven thousand employees including over two hundred people outside India in Africa, CIS, Japan and USA.

Cadila Pharmaceuticals is also partnering for growth with leading international companies worldwide in the areas of vaccine development, biological therapeutics and diagnostics, stem cell banking and hospital management. The company has also strategic alliances for preventing in-patient infections and development of novel treatment for specific and acute infections, for developing Antibiotic Resistant Breakers and innovative treatment in inflammation and pain management.

global-presence

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2017 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals